References
- Stewart BW, Wild CP, editors. World cancer report 2014. Geneva: World Health Organization; 2014.
- Madeleine MM, Daling JR, Carter JJ, et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst. 1997;89:1516–1523.
- Ferenczy A, Coutlee F, Franco E, et al. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. Can Med Assoc J. 2003;169:431–434.
- Reyes MC, Cooper K. An update on vulvar intraepithelial neoplasia: terminology and a practical approach to diagnosis. J Clin Pathol. 2014;67:290–294.
- De Vuyst H, Clifford GM, Nascimento MC, et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124:1626–1636.
- van de Nieuwenhof HP, Massuger LF, van der Avoort IA, et al. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur J Cancer. 2009;45:851–856.
- Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. Int J Gynaecol Obstet. 2015;131(Suppl 2):S76–S83.
- Alkatout I, Schubert M, Garbrecht N, et al. Vulvar cancer: epidemiology, clinical presentation, and management options. Int J Womens Health. 2015;7:305–313.
- Parkin DM, Whelan SL, Ferlay J, et al., editors. Cancer incidence in five continents. Volume VIII. IARC Scientific Publications No. 155. Lyon: International Agency for Research on Cancer; 2002.
- Curado MP, Edwards B, Shin HR, et al., editors. Cancer incidence in five continents. Volume IX. IARC Scientific Publications No. 160. Lyon: International Agency for Research on Cancer; 2007.
- Forman D, Bray F, Brewster DH, et al., editors. Cancer incidence in five continents. Volume X. IARC Scientific Publication No. 164. Lyon: International Agency for Research on Cancer; 2014.
- Buttmann-Schweiger N, Klug SJ, Luyten A, et al. Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999–2011. A population-based cancer registry analysis. PLoS One. 2015;10:e0128073.
- Robert Koch Institute, Association of Population-based Cancer Registries in Germany, editors. Cancer in Germany 2011/2012. 10th ed. Berlin: Robert Koch Institute; 2015.
- World Health Organization, editor. International classification of diseases. 9th revision. Geneva: World Health Organization; 1977.
- World Health Organization, editor. International statistical classification of diseases and related health problems. 10th revision. Geneva: World Health Organization; 1992.
- Fritz A, Percy C, Jack A, et al., editors. International classification of diseases for oncology (ICD-O). 3rd ed. Geneva: World Health Organization; 2000.
- Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.
- Beahrs OH, Henson DE, Hutter RVP, editors. Manual for staging of cancer. 3rd ed. American Joint Committee on Cancer. New York: Lippincott Company; 1988.
- White IR, Carlin JB. Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Statist Med. 2010;29:2920–2931.
- Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. Hoboken (NJ): John Wiley and Sons; 2002.
- Nur U, Shack LG, Rachet B, et al. Modelling relative survival in the presence of incomplete data: a tutorial. Int J Epidemiol. 2009;39:118–128.
- Beller U, Quinn MA, Benedet JL, et al. Carcinoma of the vulva. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S7–S27.
- R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2014.
- Hampl M, Deckers-Figiel S, Hampl JA, et al. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol. 2008;109:340–345.
- Robert Koch Institute, Association of Population-based Cancer Registries in Germany, editors. Cancer in Germany 2009/2010. 9th ed. Berlin: Robert Koch Institute; 2013.
- Akhtar-Danesh N, Elit L, Lytwyn A. Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: a population-based study. Gynecol Oncol. 2014;134:314–318.
- Schuurman MS, van den Einden LC, Massuger LF, et al. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. Eur J Cancer. 2013;49:3872–3880.
- Sigusch V. On cultural transformations of sexuality and gender in recent decades. Ger Med Sci. 2004;2:Doc07.
- Bruni L, Diaz M, Castellsague X, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202:1789–1799.
- European Centre for Disease Prevention and Control, WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2014. Stockholm: ECDC, 2015.
- Becker N. Epidemiological aspects of cancer screening in Germany. J Cancer Res Clin Oncol. 2003;129:691–702.
- The Federal Health Monitoring System. Chart 3.2.7: Utilization of statutory measures for the early detection of cancer (in Percent; starting from 1991) Bonn: Federal Statistical Office; 2016 [cited 2016 November 21]. Available from: http://www.gbe-bund.de/gbe10/ergebnisse.prc_tab?fid =10607&suchstring=&query_id=&sprache=D&fund_typ=GRA&methode=&vt=&verwandte =1&page_ret =0&seite =1&p_lfd_nr =10&p_news=&p_sprachkz=D&p_uid=gast&p_aid =7554746&hlp_nr =1&p_janein=J.
- Saarland Health Monitoring System. [Utilization of statutory measures for the early detection of cancer. Classification: years, Saarland, age, sex (starting from 1995)] Saarbrücken: Ministry of Social Affairs, Public Health, Women and Family Affairs; 2016 [cited 2016 November 21]. Available from: http://www.gbe.saarland.de/medien/download/07_016_2014.htm.
- Hauspy J, Beiner M, Harley I, et al. Sentinel lymph node in vulvar cancer. Cancer. 2007;110:1015–1023.
- Batzler WU, Hundsdörfer G, Schön D, et al., editors. Krebs in Deutschland. Dritte erweiterte, aktualisierte Ausgabe. Saarbrücken: Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland; 2002.
- Sant M, Chirlaque Lopez MD, Agresti R, et al. Survival of women with cancers of breast and genital organs in Europe 1999–2007: results of the EUROCARE-5 study. Eur J Cancer. 2015;51:2191–2205.
- Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley and Sons; 1987.
- Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604–1608.
- Homesley HD, Bundy BN, Sedlis A, et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol. 1993;49:279–283.
- De Cicco C, Sideri M, Bartolomei M, et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer. 2000;82:295–299.
- Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–889.
- Woelber L, Trillsch F, Kock L, et al. Management of patients with vulvar cancer: a perspective review according to tumour stage. Ther Adv Med Oncol. 2013;5:183–192.
- Hampl M, Sarajuuri H, Wentzensen N, et al. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol. 2006;108:1361–1368.
- Li K-H, Meng X-L, Raghunathan TE, et al. Significance levels from repeated P-values with multiply-imputed data. Stat Sin. 1991;1:65–92.